-
15 May 2025 16:18:34
- Source: Sharecast
15 May 2025
Iconic Labs Plc
("Iconic" or the "Company")
Result of AGM
Iconic Labs Plc (LSE:ICON) is pleased to announce that at the Annual General Meeting ("AGM") held earlier today, Resolutions 1 to 9 were all were duly approved by shareholders by way of a poll.
The results of the poll were as follows:
|
|
Resolutions |
For |
% |
Against |
% |
Withheld |
|
1 |
To receive and adopt the accounts for the financial year ended 30 June 2024. |
3,704,201 |
99.96% |
1,303 |
0.04% |
1,561 |
|
2 |
To re-appoint RPG Chartered Accountants as Auditors. |
3,702,067 |
99.91% |
3,437 |
0.09% |
1,561 |
|
3 |
To authorise the Directors to determine the remuneration of the Auditors. |
3,703,158 |
99.95% |
1,799 |
0.05% |
2,108 |
|
4 |
To re-appoint John Farquharson as a Director. |
3,687,130 |
99.53% |
17,487 |
0.47% |
2,448 |
|
5 |
To re-appoint Bela Lendvai-Lintner as a Director. |
3,697,050 |
99.80% |
7,567 |
0.20% |
2,448 |
|
6 |
To re-appoint Victor Humberdot as a Director. |
3,698,465 |
99.83% |
6,152 |
0.17% |
2,448 |
|
7 |
To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £2,985,223.22. |
3,698,431 |
99.82% |
6,663 |
0.18% |
1,971 |
|
|
Special Resolutions: |
|
|
|
|
|
|
8 |
To empower the Directors to generally allot relevant equity securities. |
3,698,666 |
99.83% |
6,428 |
0.17% |
1,971 |
|
9 |
To authorise the Directors to make market purchases of own shares. |
3,702,532
|
99.92% |
2,971 |
0.08% |
1,562 |
ENDS
For more information, please contact:
|
Iconic Labs
John Farquharson Chief Executive Officer
|
Tel: +44 (0) 7462 156238 |
|
Novum Securities Limited David Coffman / Daniel Harris |
Tel: +44 (0) 20 7399 9400
|
|
Yellow Jersey PR Charles Goodwin Annabelle Wills Bessie Elliot
|
Tel: +44 (0) 20 3004 9512 iconic@yellowjerseypr.com
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.